← Human Trials & Peer-Reviewed Studies

Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females--a general clinical research center-based study.

Plain-language guide to PMID 10902783 (2000): clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 58 children.

Key Facts

PMID
10902783
Journal
The Journal of clinical endocrinology and metabolism
Year
2000
Study type
Clinical Trial
Authors
Veldhuis JD et al. (3 authors)
DOI
10.1210/jcem.85.7.6697

What This Study Did, in Plain Language

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this clinical trial publication.

The researchers quantitated the principal regulated facets of GH release by 1) deconvolution analysis to assess basal vs. pulsatile GH secretion, 2) approximate entropy to compute the regularity of GH release patterns, and 3) cosine regression analysis to evaluate the overnight rhythmic release of GH.

Why It Was Studied

Although numerous studies have delineated an impact of gender on the neuroendocrine control of GH secretion in the adult, few investigations have defined the nature and extent of sex differences before puberty.

This deficit reflects jointly the sensitivity limitations of earlier GH assays and the paucity of intensive sampling protocols in healthy children.

Who Took Part

According to the abstract, 58 children were involved.

By PubMed's age tags, the people studied were children and teenagers, both men and women.

How the Study Was Run

Males and females were evaluated in prepuberty (n = 17 boys; n = 11 girls) and late adolescence (n = 13 males; n = 17 females).

What Was Measured

Topics PubMed links to this paper include Aging, Entropy, Human Growth Hormone, Luminescent Measurements, Nervous System Physiological Phenomena, Regression Analysis and Sex Characteristics.

What This Means in Plain Language

This is a clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 58 children.

The publication is from 2000 (The Journal of clinical endocrinology and metabolism), a journal based in United States.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.

Our Notes on the Compound

Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.